255 related articles for article (PubMed ID: 9562336)
1. Effect of ebselen on IL-1-induced alterations in cartilage metabolism.
Pratta MA; Ackerman NR; Arner EC
Inflamm Res; 1998 Mar; 47(3):115-21. PubMed ID: 9562336
[TBL] [Abstract][Full Text] [Related]
2. Independent effects of interleukin-1 on proteoglycan breakdown, proteoglycan synthesis, and prostaglandin E2 release from cartilage in organ culture.
Arner EC; Pratta MA
Arthritis Rheum; 1989 Mar; 32(3):288-97. PubMed ID: 2784682
[TBL] [Abstract][Full Text] [Related]
3. Effects of meloxicam, compared with other NSAIDs, on cartilage proteoglycan metabolism, synovial prostaglandin E2, and production of interleukins 1, 6 and 8, in human and porcine explants in organ culture.
Rainsford KD; Ying C; Smith FC
J Pharm Pharmacol; 1997 Oct; 49(10):991-8. PubMed ID: 9364409
[TBL] [Abstract][Full Text] [Related]
4. Effects of R and S enantiomers and a racemic mixture of carprofen on the production and release of proteoglycan and prostaglandin E2 from equine chondrocytes and cartilage explants.
Armstrong S; Lees P
Am J Vet Res; 1999 Jan; 60(1):98-104. PubMed ID: 9918155
[TBL] [Abstract][Full Text] [Related]
5. Strong inhibition of mammalian lipoxygenases by the antiinflammatory seleno-organic compound ebselen in the absence of glutathione.
Schewe C; Schewe T; Wendel A
Biochem Pharmacol; 1994 Jul; 48(1):65-74. PubMed ID: 8043032
[TBL] [Abstract][Full Text] [Related]
6. Modulation of interleukin-1-induced alterations in cartilage proteoglycan metabolism by activation of protein kinase C.
Arner EC; Pratta MA
Arthritis Rheum; 1991 Aug; 34(8):1006-13. PubMed ID: 1859477
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants.
Hardy MM; Seibert K; Manning PT; Currie MG; Woerner BM; Edwards D; Koki A; Tripp CS
Arthritis Rheum; 2002 Jul; 46(7):1789-803. PubMed ID: 12124863
[TBL] [Abstract][Full Text] [Related]
8. Ebselen augments its peroxidase activity by inducing nrf-2-dependent transcription.
Tamasi V; Jeffries JM; Arteel GE; Falkner KC
Arch Biochem Biophys; 2004 Nov; 431(2):161-8. PubMed ID: 15488464
[TBL] [Abstract][Full Text] [Related]
9. The effect of ebselen on polymorphonuclear leukocyte migration to joints in rats with adjuvant arthritis.
Gao JX; Issekutz AC
Int J Immunopharmacol; 1993 Oct; 15(7):793-802. PubMed ID: 8262693
[TBL] [Abstract][Full Text] [Related]
10. Arthritis and cannabinoids: HU-210 and Win-55,212-2 prevent IL-1alpha-induced matrix degradation in bovine articular chondrocytes in-vitro.
Mbvundula EC; Bunning RA; Rainsford KD
J Pharm Pharmacol; 2006 Mar; 58(3):351-8. PubMed ID: 16536902
[TBL] [Abstract][Full Text] [Related]
11. Ebselen has dehydroascorbate reductase and thioltransferase-like activities.
Jung CH; Washburn MP; Wells WW
Biochem Biophys Res Commun; 2002 Mar; 291(3):550-3. PubMed ID: 11855823
[TBL] [Abstract][Full Text] [Related]
12. Protection by ebselen against cisplatin-induced nephrotoxicity: antioxidant system.
Husain K; Morris C; Whitworth C; Trammell GL; Rybak LP; Somani SM
Mol Cell Biochem; 1998 Jan; 178(1-2):127-33. PubMed ID: 9546591
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase inhibition lowers prostaglandin E2 release from articular cartilage and reduces apoptosis but not proteoglycan degradation following an impact load in vitro.
Jeffrey JE; Aspden RM
Arthritis Res Ther; 2007; 9(6):R129. PubMed ID: 18096078
[TBL] [Abstract][Full Text] [Related]
14. Cytokine-induced cartilage proteoglycan degradation is mediated by aggrecanase.
Arner EC; Hughes CE; Decicco CP; Caterson B; Tortorella MD
Osteoarthritis Cartilage; 1998 May; 6(3):214-28. PubMed ID: 9682788
[TBL] [Abstract][Full Text] [Related]
15. Differential direct effects of cyclo-oxygenase-1/2 inhibition on proteoglycan turnover of human osteoarthritic cartilage: an in vitro study.
Mastbergen SC; Jansen NW; Bijlsma JW; Lafeber FP
Arthritis Res Ther; 2006; 8(1):R2. PubMed ID: 16356188
[TBL] [Abstract][Full Text] [Related]
16. Effect of interleukin-1-beta and tumor necrosis factor-alpha on cartilage proteoglycan metabolism in vitro.
Pratta MA; Di Meo TM; Ruhl DM; Arner EC
Agents Actions; 1989 Jun; 27(3-4):250-3. PubMed ID: 2801305
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and release of human cartilage matrix proteoglycans are differently regulated by nitric oxide and prostaglandin-E2.
Mastbergen SC; Bijlsma JW; Lafeber FP
Ann Rheum Dis; 2008 Jan; 67(1):52-8. PubMed ID: 17485421
[TBL] [Abstract][Full Text] [Related]
18. Requirement for protein kinase R in interleukin-1alpha-stimulated effects in cartilage.
Tam CL; Hofbauer M; Towle CA
Biochem Pharmacol; 2007 Dec; 74(11):1636-41. PubMed ID: 17850766
[TBL] [Abstract][Full Text] [Related]
19. Ebselen, a glutathione peroxidase mimetic seleno-organic compound, as a multifunctional antioxidant. Implication for inflammation-associated carcinogenesis.
Nakamura Y; Feng Q; Kumagai T; Torikai K; Ohigashi H; Osawa T; Noguchi N; Niki E; Uchida K
J Biol Chem; 2002 Jan; 277(4):2687-94. PubMed ID: 11714717
[TBL] [Abstract][Full Text] [Related]
20. Catabolin/interleukin-1 regulation of cartilage and chondrocyte metabolism.
O'Byrne EM; Schroder HC; Stefano C; Goldberg RL
Agents Actions; 1987 Aug; 21(3-4):341-4. PubMed ID: 3500596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
